To achieve the goal of subtype-specific BC detection, we selected from our BC subtype-specific EV proteomes, 64 TNBC, and 73 HER2-positive EV proteins, which can be used as potential signatures for diagnostic and/or stratification between different breast cancer subtypes, illustrating disease etiology considerably better than whole-cell proteome signatures. Here, ERBB2 is linked to breast carcinoma.